Hansa Medical’s rights issue oversubscribed
An extraordinary general meeting held on March 5, 2014, resolved to carry through a rights issue of at the most 3 704 229 shares with preferential rights at SEK 10 per share. The subscription period for the offer was between March 25 and April 8.
In total 3 658 875 shares have been subscribed for with preferential rights, which corresponds to 99 percent of the number of shares issued. In addition, 1 417 323 shares were subscribed for without preferential rights, corresponding to 38 percent of the number of shares issued. Shares being subscribed for without preferential rights will be assigned according to the principles described in the prospectus published on March 19, 2014. No rights issue guarantee will be applied due to the oversubscription of the rights issue.
The rights issue increases the number of Hansa Medical shares with 3 704 229 shares to a total amount of 25 929 603 shares. Following the rights issue, the share capital amounts to 25 929 603.
Paid subscribed shares, subscribed with preferential rights, is traded under short name HMED BTA 1 at NASDAQ OMX First North until the end of April when they will be converted to shares. Paid subscribed shares, subscribed without preferential rights, will be traded under short name HMED BTA 2 starting at the end of next week.
For further information, please contact:
Hansa Medical AB
Emanuel Björne, CEO Hansa Medical AB (publ)
Mobile: 46 707 17 54 77
E-mail: emanuel.bjorne@hansamedical.com
www.hansamedical.com